Lates News

On March 20, Ling Ji, Vice Minister of the Ministry of Commerce and Deputy Representative for International Trade Negotiations, met with Lin Yiming, Executive Vice President of Danish pharmaceutical company Novo Nordisk, to exchange views on the operation of the company in China and the opportunities for open development in China. Ling Ji stated that in recent years, China's technology innovation capability has rapidly improved and the scale of the pharmaceutical and health industry has continued to expand. China has become a global innovation source with new productive forces promoting high-quality economic development. He hopes Novo Nordisk will continue to deepen its presence in the Chinese market and contribute to building a healthy China. Lin Yiming expressed that Novo Nordisk is optimistic about China's huge market potential and highly appreciates the Chinese government's continuous efforts to optimize the business environment and strengthen intellectual property protection. They are willing to further increase investment in China, expand localization production and research and development, and support the vigorous development of the Chinese pharmaceutical and health industry (Ministry of Commerce).